GLP-1 Receptor Agonists: Metabolic Regulators GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda), suppress appetite, enhance insulin sensitivity, and promote weight loss by mimicking the incretin hormone GLP-1
Wegovy and Zepbound are commonly prescribed options, depending on individual health needs and goals
The medication can slow gastric emptying (the movement of food out of your stomach), so it may affect how well oral medications are absorbed if you take them at the same time
[114] For many inflammatory conditions, initial doses may range from 5 to 60 mg daily, depending on the severity of the condition and the urgency of treatment required
Weight loss was consistent and progressive, starting at 3.93% at three months and reaching 7.87% at twelve months. In addition, several case series studies have demonstrated benefits of GLP-1s in kidney and pancreas transplant recipients, including lowering blood glucose levels and providing renal protective effects. GLP-1 RAs would be advantageous in liver transplant recipients due to their renal clearance, avoiding interference with immunosuppressant drug metabolism